"What is fundamentally needed now is something on that post-approval side of the equation where the market for this ecosystem does not work," said @IAmBiotech's Emily Wheeler on sustaining #antimicrobial development at a recent @UCLACollege event on #AMR. buff.ly/3vQDvXr
0
0
6
115
0